Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson’s disease-Reference-Cited by-同舟云学术

Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson’s disease

Published:2010-02 Issue:2 Volume:133 Page:496-511
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Björklund Tomas,Carlsson Thomas,Cederfjäll Erik Ahlm,Carta Manolo,Kirik Deniz

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/133/2/496/16697345/awp314.pdf

Reference69 articles.

1. Reversal by l-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice;Ahlenius;Brain Res,1974

2. Restoration of locomotor activity in mice by low l-DOPA doses after suppression by alpha-methyltyrosine but not by reserpine;Ahlenius;Brain Res,1973

3. l-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study;Arai;Neurosci Lett,1995

4. Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous l-DOPA in the rat, with reference to the involvement of aromatic L-amino acid decarboxylase;Arai;Brain Res,1994

5. Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study;Arai;Brain Res,1996

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potentials of autophagy enhancing natural products in the treatment of Parkinson disease;Drug Metabolism and Personalized Therapy;2021-08-13

2. Potentials of autophagy enhancing natural products in the treatment of Parkinson disease;Drug Metabolism and Personalized Therapy;2021-08-13

3. Strategies for delivering therapeutics across the blood–brain barrier;Nature Reviews Drug Discovery;2021-03-01

4. Stereotaxic Intracranial Delivery of Chemicals, Proteins or Viral Vectors to Study Parkinson's Disease;Journal of Visualized Experiments;2021-02-18

5. Treatment of Parkinson’s Disease by MAO-B Inhibitors, New Therapies and Future Challenges - A Mini-Review;Combinatorial Chemistry & High Throughput Screening;2020-12-22